Genome editing in human pluripotent stem cells
StemBook2014
Citations Over TimeTop 10% of 2014 papers
Abstract
Genome editing is used to make targeted modifications to the genome of eukaryotic cells. There are many potential applications of genome editing in human pluripotent stem cells (hPSCs) including the generation of knockout and reporter cell lines. This protocol describes a system for efficient genome editing in hPSCs using engineered transcription activator-like effector nucleases (TALENs) or clustered regularly interspaced short palindromic repeat (CRISPR) technology.
Related Papers
- → Temperature effect on CRISPR-Cas9 mediated genome editing(2017)108 cited
- → Genome editing for targeted improvement of plants(2016)44 cited
- → Front-line of genome editing technology for animal cell engineering(2015)3 cited
- → Role of CRISPR-Cas/9 in Hematological Disorders: A Review(2021)1 cited
- Conference Announcement on Genome Editing and Gene Therapy(2019)